Dr. Alexander Heifetz is a Principal Scientist at Evotec (UK) Ltd, a drug discovery services company. He provides CADD expert support for drug discovery programs. He obtained his PhD from the Weizmann Institute of Science, Israel, in 2001 under supervision of former Israeli president and Foreign Member of the Royal Society, Prof. Ephraim Katzir and Dr. Miriam Eisenstein. Dr. Heifetz has more than 12 years of experience in drug discovery industry (EPIX Pharmaceuticals and Evotec) and was involved in discovery of 3 clinical drug candidates for treatment of anxiety, major depressive disorder, pulmonary hypertension, and Alzheimer’s disease. He has more than 18 patents, patent applications and a wide range of publications in the area of medicinal chemistry and molecular modelling. Recently, he received the Royal Society Industry Award and established a collaboration with academic group of Dr. Phillip Biggin from the University of Oxford, for development of methods for GPCR modelling.
Medicinal chemistry, molecular modeling, drug discovery